Quantitative Single Cell Mass Spectrometry for Small Molecules with Unprecedented Sensitivity

具有前所未有的灵敏度的小分子定量单细胞质谱分析

基本信息

  • 批准号:
    10709859
  • 负责人:
  • 金额:
    $ 22.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-24 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Fundamental understanding of the development of cellular metabolic heterogeneity and its impact on cell response to stimuli has ramifications on nearly every aspect of biomedical research including disease diagnosis, treatment and prevention. Cellular metabolism is naturally heterogeneous and prediction of cellular response to stimuli will depend on the distribution of intracellular metabolite concentrations across a cell population. However, for small molecules and therapeutics direct empirical measure of intracellular concentrations is rare, though many drugs target inside the cell and require reaching their site of action at a specific concentration to be effective. Their quantitative distribution in a cell population is a key, currently unmeasurable, variable to understanding many drug’s pharmacological and toxicological effects. The best way to deconvolute heterogeneous cell response is to individually profile each cell in the population. Unfortunately, current single cell analysis approaches for measuring small molecules lack a number of critical features needed to make analysis routine. An ideal single cell characterization method must be quantitative, fast, robust, sensitive, applicable to a range of cell types and be able to measure a wide range of molecules. The lack of such a system restricts detailed investigations into the fundamental mechanisms underpinning heterogeneous cell response; foundational information needed for advancing disease diagnosis, treatment and prevention as part of the mission of National Institute of General Medical Sciences (NIGMS). The goal of this research is to evaluate a high-risk/high-reward approach, pulsed single cell mass spectrometry (p-SC-MS), a novel concept of capturing, lysing and analyzing single cells with significantly improved sensitivity and throughput over existing single cell analysis methodologies for small molecules. Our approach requires overcoming high-risk challenges in droplet capture and cell lysis at small scale and under a high electric field environment. This risk is offset by a correspondingly high reward: massively increased sensitivity (>50,000X), single cell analysis throughput (>6X) and cell media tolerance over the current state-of- the-art. The platform is easy to use and will be shown to be applicable for many cell types through three specific aims tackling the feasibility of the concept. Specific Aim #1: Demonstrate single cell droplet-on-demand capture and metabolite extraction using a custom pulsed-nanoelectrospray ionization source. Specific Aim #2: Validate the quantitative accuracy of p-SC-MS through measure of amiodarone (AMIO) and N-desethylamiodarone (NDEA) in single HepG2 cells. Specific Aim #3: Demonstrate measure and comparison of metabolites and lipids in HeLa, HepG2, MD-AMB, BT-474 and OK-F6 cell lines in complex media. The end product of this research will be a novel, high-impact technology that enables chemical characterization of small molecules from single cells with a massive >50,000X improvement in sensitivity and 6X improvement in speed over current art, enabling resolution of intracellular molecular distributions.
项目总结

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vilmos Kertesz其他文献

Vilmos Kertesz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vilmos Kertesz', 18)}}的其他基金

Quantitative Single Cell Mass Spectrometry for Small Molecules with Unprecedented Sensitivity
具有前所未有的灵敏度的小分子定量单细胞质谱分析
  • 批准号:
    10431204
  • 财政年份:
    2022
  • 资助金额:
    $ 22.84万
  • 项目类别:

相似海外基金

Connecting Subcellular Electrophysiology to Patient Arrhythmia: A Case Study of Amiodarone
将亚细胞电生理学与患者心律失常联系起来:胺碘酮的案例研究
  • 批准号:
    10795635
  • 财政年份:
    2022
  • 资助金额:
    $ 22.84万
  • 项目类别:
Analgesic effects and sensory neuron selectivity of amiodarone
胺碘酮的镇痛作用和感觉神经元选择性
  • 批准号:
    19KK0417
  • 财政年份:
    2020
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Clinical implication of lipoprotein-binding in therapeutic drug monitoring of amiodarone
脂蛋白结合在胺碘酮治疗药物监测中的临床意义
  • 批准号:
    19K07188
  • 财政年份:
    2019
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of lung surfactant metabolism of alveolar type II cells in amiodarone-induced interstitial pneumonia
胺碘酮诱导间质性肺炎肺泡II型细胞肺表面活性物质代谢分析
  • 批准号:
    18K08191
  • 财政年份:
    2018
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Neuroprotective effects of amiodarone
胺碘酮的神经保护作用
  • 批准号:
    17K11044
  • 财政年份:
    2017
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of arrhythmia control by amiodarone on the pharmacokinetics of immunosuppressants in heart transplant patients.
胺碘酮控制心律失常对心脏移植患者免疫抑制剂药代动力学的影响。
  • 批准号:
    17K08476
  • 财政年份:
    2017
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Amiodarone does not affect brain injury in a rat model of transient forebrain ischemia.
胺碘酮不会影响短暂前脑缺血大鼠模型的脑损伤。
  • 批准号:
    26462763
  • 财政年份:
    2014
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cellular Basis for the Antifungal Activity of Amiodarone
胺碘酮抗真菌活性的细胞基础
  • 批准号:
    7879726
  • 财政年份:
    2009
  • 资助金额:
    $ 22.84万
  • 项目类别:
Pediatric Acceptable Formulation of Amiodarone
儿科可接受的胺碘酮配方
  • 批准号:
    7745171
  • 财政年份:
    2009
  • 资助金额:
    $ 22.84万
  • 项目类别:
Transferring knowledge of amiodarone safety monitoring to the community practice setting using a formalized care pathway
使用正规护理途径将胺碘酮安全监测知识转移到社区实践环境中
  • 批准号:
    179181
  • 财政年份:
    2008
  • 资助金额:
    $ 22.84万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了